Hudson Bay Capital Management LP Amicus Therapeutics, Inc. Transaction History
Hudson Bay Capital Management LP
- $28.9 Billion
- Q1 2025
A detailed history of Hudson Bay Capital Management LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 2,470,410 shares of FOLD stock, worth $15 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,470,410
Previous 1,804,800
36.88%
Holding current value
$15 Million
Previous $17 Million
18.57%
% of portfolio
0.07%
Previous 0.07%
Shares
25 transactions
Others Institutions Holding FOLD
# of Institutions
315Shares Held
319MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$177 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$176 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$148 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$130 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$124 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.7B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...